The biotechnology market is an ever-expanding, demanding, controversial and lucrative market. As long as the need for something better and the hunger for knowledge exist, biotechnology will be the crux for much crucial development and enhancement.

The biotechnology market covers a large area, and has vast and crucial branches among them. Some of these areas are agriculture GMO, antibody technologies, antisense technology, biomaterials, biopharmaceuticals, drug discovery, emerging technology, environmental/industrial biotechnology, enzymes, gene therapy, general biotechnology, genetic engineering, genomics, informatics, instrumentation and equipment, molecular biology, pharmaceuticals, proteomics, regulation and bioethics, research and development, tissue engineering and wound care.

There are more than 90 biotechnology products in existence in the world today, including drugs and vaccines which have been approved by the U.S. Food and Drug Administration (FDA). Apart from these, the research and development is still going strong, with over 350 biotechnology drug products and vaccines still in human clinical trials. They give hope to the sufferers of many incurable and unstoppable diseases ravaging the population, such as cancer, AIDS, Alzheimers disease, diabetes, multiple sclerosis and other grave conditions.

We can see major improvements in the advancement of medicine; however, we should also keep in mind the notable advancements in the field of agriculture, the use of biopesticides to reduce the hazardous effects of pesticides to the environment and to the crops, and the many ways biotechnology has helped the fields of pharmaceuticals and chemicals, energy and environmental management.

Biotechnology is also a lucrative market, as the biotech companies and the biotech industry generate revenue in the region of $50 billion a year.